Activating mutations most often occur in the kinase domain, leading to increased ALK downstream signaling via the PI3K/AKT, RAS/MAPK and JAK/STAT pathways, promoting neuroblastoma cell survival and proliferation [14–19, 22–24]. The gene discussed is ALK; the disease is neuroblastoma.